Pharmafile Logo
Pharmafocus logo
Advanced Search
blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025
Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …

News

Hansa Biopharma appoints Renée Aguiar-Lucander as CEO

April 24, 2025
Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …

Appointment

Neurizon makes appointments to executive team

April 24, 2025
Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …

Appointment

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025
Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …

News

Dual immunotherapy for bowel cancer now available under NHS

April 23, 2025
Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …

News

CARBOGEN AMCIS manufacturing license advances services in China

April 23, 2025
Manufacturing Services, Manufacturing and Production Carbogen Amcis, China, Corporate, Drug Manufacturing License (DML), Shanghai, manufacturing

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has been successfully granted Drug Manufacturing …

News
handshake_2

AOTI diabetic foot care therapy to be used by NHS

April 23, 2025
Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …

News

Galapagos announces leadership changes amid planned company split

April 22, 2025
Analytical & Laboratory Services, Research and Development CEO Appointment, Corporate, Galapagos, cell therapy

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been …

Appointment

Kidney Research UK backs digital innovation to support 15 million patients with long-term conditions

April 22, 2025
Medical Education, Patient Awareness Programmes, Public Relations Cognitant Group, Kidney Research UK, Nephrology, chronic kidney disease (CKD)

Kidney Research UK has announced an ambitious investment in the patient engagement platform Healthinote, developed by Cognitant Group, in a …

News

Meribel Pharma Solutions launches to take pharma services to new heights

April 22, 2025
Manufacturing Services, Manufacturing and Production CMDO, Corporate, Meribel Pharma Solutions, manufacturing

Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched with operations across 13 sites …

News

Allegro confirms successful safety testing of osteoarthritis treatment

April 17, 2025
Research and Development Allegro, Osteoporosis, joint disease, oesteoarthritis, pretrial

Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …

News
blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

April 16, 2025
Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …

News

Astraveus expands leadership team ahead of Lakhesys launch

April 16, 2025
Manufacturing Services Astraveus, Corporate, appointment

Astraveus has announced a series of senior appointments as it advances towards the launch of its Lakhesys Benchtop Cell Factory, …

Appointment

Moderna authorised to upscale development of mRNA vaccines in UK

April 15, 2025
Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination

Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …

News

ProQR appoints new CFO and CMO to drive clinical-stage growth

April 15, 2025
Research and Development Corporate, ProQR, appointments, clinical development

ProQR Therapeutics announced two major leadership appointments to support its transition into the clinical development phase of its RNA editing …

Appointment

Survey suggests Britons with a disability are concerned over AI-integrated healthcare

April 14, 2025
Business Services, Consultancy, Medical Communications AI, Consultancy, Corporate, Pharmacy, nuom, survey

A survey conducted by nuom, a British healthcare consultancy, found a majority of UK adults with a disability are concerned …

News

Successful trial results announced for potential rare eye disease treatment

April 14, 2025
Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease

Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …

News

Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch

April 14, 2025
Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease

International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …

News
blood-1813410_960_720

First cohort dosed with potential treatment for Von Willebrand disease

April 11, 2025
Research and Development Haematology, Hemab Therapeutics, Richmond Pharma, Von Willebrand Disease, bleeding disorder

UK-based clinical trials company, Richmond Pharmacology, has completed the first stage of Velora Pioneer, a phase 1/2 clinical trial investigating …

News

Inbiome’s rapid diagnostic platform approved for EU use, cuts infection identification time to just five hours

April 11, 2025
Research and Development Diagnostics, EU, Inbiome

Dutch diagnostics firm Inbiome has received In Vitro Diagnostic Regulation (IVDR) certification from the EU for its Molecular Culture ID …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026